We are live on ! Find out more
COCH icon

Envoy Medical
COCH

94 hedge funds and large institutions have $362M invested in Envoy Medical in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

9% more capital invested

Capital invested by funds: $331M → $362M (+$30.8M)

6.7% more ownership

Funds ownership: 80.61% → 87.31% (+6.7%)

6% more funds holding

Funds holding: 89 → 94 (+5)

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
23
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$11.1M
2
MF
Magnetar Financial
Illinois
+$10.7M
3
Millennium Management
Millennium Management
New York
+$6.72M
4
DCM
Difesa Capital Management
New York
+$3.08M
5
HCM
Highbridge Capital Management
New York
+$2.95M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$9.06M
2
HI
HBK Investments
Texas
-$7.5M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$3.52M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.94M
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$4.2M -$420K -42,813 -9%
AA
27
AQR Arbitrage
Connecticut
$4.14M +$494K +50,298 +14%
LA
28
Linden Advisors
New York
$3.91M – – –
FTCM
29
First Trust Capital Management
Illinois
$3.48M +$2.88M +292,838 +472%
DCM
30
Difesa Capital Management
New York
$3.09M +$3.08M +313,911 New
HCM
31
Highbridge Capital Management
New York
$2.95M +$2.95M +300,403 New
DCM
32
Dupont Capital Management
Delaware
$2.95M – – –
BCM
33
BlueCrest Capital Management
Jersey
$2.95M +$2.95M +300,000 New
CCA
34
Castle Creek Arbitrage
Colorado
$2.89M – – –
CF
35
Cantor Fitzgerald
New York
$2.88M – – –
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$2.6M – – –
AIMCA
37
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.46M +$2.45M +250,000 New
CSS
38
Cubist Systematic Strategies
Connecticut
$2.27M +$159K +16,222 +8%
WAM
39
Wolverine Asset Management
Illinois
$2.15M +$1.99M +202,810 +1,286%
Jane Street
40
Jane Street
New York
$1.99M +$1.99M +202,230 New
Goldman Sachs
41
Goldman Sachs
New York
$1.97M -$9.06M -922,315 -82%
Capstone Investment Advisors
42
Capstone Investment Advisors
New York
$1.96M – – –
GL
43
Governors Lane
New York
$1.96M – – –
GCM
44
Ghisallo Capital Management
Massachusetts
$1.84M – – –
ASM
45
ATW SPAC Management
New York
$1.71M +$982K +100,000 +134%
CC
46
Centiva Capital
New York
$1.68M – – –
CH
47
CVI Holdings
Delaware
$1.5M – – –
SCM
48
Segantii Capital Management
Hong Kong
$1.48M – – –
TCM
49
Tenor Capital Management
New York
$1.47M – – –
CM
50
Cohanzick Management
New York
$1.44M +$432K +43,976 +43%
1
2
3 4 5

COCH Hedge Fund Activity: Q3 2022 in Review

94 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2022, worth a combined $362M — up 9.3% from $331M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 9 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.

The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11.1M. The largest seller was Goldman Sachs, cutting an estimated $9.06M.

  • 94 institutional investors held Envoy Medical (COCH) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $362M of Envoy Medical stock for Q3 2022, up 9.3% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q3 2022 and 9 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11.1M added.
  • The largest Envoy Medical seller in Q3 2022 was Goldman Sachs, an estimated $9.06M sold.

Based on aggregated 13F filings for Q3 2022.